• Corpus ID: 7855481

The Modern Merits of South Koreas Biopharmaceutical Industry

@article{Rymzo2016TheMM,
  title={The Modern Merits of South Koreas Biopharmaceutical Industry},
  author={Benjamin Rymzo and Nathan J. Dowden and Regina S. Salvat and Tom Lee},
  journal={International Journal of Drug Development and Research},
  year={2016},
  volume={8}
}
The overview: In recent years, the South Korean economy has evolved from light goods, to heavy industry, to high tech and biotech. Along the way, the country has built a thoroughly modern legal and regulatory framework, an arguably world class educational infrastructure, and an unusually productive level of public-private partnership activity. How did it get here?: Migrating from a heavy manufacturing economy in the aftermath of the Korean War, South Korea began turning its attention to… 

Figures from this paper

The Modern Merits of South Koreas Biopharmaceutical Industry

From these actions, South Korea now ranks among the leading nations on other development indicators such as healthcare, education and R&D expenditure, and is now higher than the OECD average at 81 years old.

References

SHOWING 1-10 OF 55 REFERENCES

Globalization and Change in the Japanese Pharmaceutical Industry, 1990–2010

In the 1990s, the Japanese pharmaceutical industry faced a crisis caused by the government’s decision to open the domestic market toforeign competition.1 Prior to the 1990s, Japan’s pharmaceutical

Creating Korea's future economy : innovation, growth, and Korea-US economic relations

South Korean President Park Geun-hye has made the development of a "creative economy" the core of her administrations economic agenda. This focus is closely linked with the goal of promoting economic

Korea’s Economic Miracle, 1962–89

This chapter examines the major factors behind the remarkable transformation of the Korean economy described in Chapter 1. Section 2 provides a brief overview of developments in key macroeconomic

Lessons from (S) Korea

After examining the critical role of the two five year plans (1962-67, focusing on infrastructure development and import substitution; 1967-72, emphasising export oriented industrialisation) in the

Current Status of Bioindustry in South Korea

The article is about the research portfolio of South Korea. It also touches on South Korea's competitive edge over other Asia countries. It includes a table on the South Korean Bioindustry Sectors.

Inequality and Industrial Change: The Legacy of the HCI: An Empirical Analysis of Korean Industrial Policy

While much has been written on the successes and failures of industrial policies, systematic evaluation of their effects remains difficult. This paper presents an approach based on a combination of

Industrial Organization and Trade Liberalization: Evidence from Korea

Drawing on evidence about industrial organization and market structure, the authors develop a computable general equilibrium model in selected industrial sectors with increasing returns to scale.

The Modern Merits of South Koreas Biopharmaceutical Industry

From these actions, South Korea now ranks among the leading nations on other development indicators such as healthcare, education and R&D expenditure, and is now higher than the OECD average at 81 years old.
...